Deciphera Pharmaceuticals, Inc.
NASDAQ:DCPH
25.59 (USD) • At close June 10, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| -194.942 | -178.931 | -299.964 | -266.489 | -192.256 | -99.854 | -50.284 | -25.94 | -19.816 |
| Depreciation & Amortization
| 2.1 | 2.946 | 3.014 | 2.305 | 0.83 | 0.317 | 0.15 | 0.09 | 0.073 |
| Deferred Income Tax
| -7.397 | 0 | 1.782 | -1.618 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 50.603 | 51.942 | 46.078 | 37.137 | 20.41 | 0 | 4.866 | 1.487 | 2.557 |
| Change In Working Capital
| -1.536 | -31.648 | 0.82 | -13.852 | 25.719 | 3.066 | 8.556 | 1.267 | 1.826 |
| Accounts Receivables
| -9.345 | -1.784 | -6.699 | -13.896 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| -0.386 | -7.109 | -10.155 | -3.241 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 7.777 | 5.319 | 0.833 | -7.533 | 10.862 | 3.991 | 2.904 | -0.187 | 1.176 |
| Other Working Capital
| 1.954 | -28.074 | 16.841 | 10.818 | 14.857 | -0.925 | 5.652 | 1.454 | 0.65 |
| Other Non Cash Items
| 4.475 | 2.829 | 7.446 | 2.834 | -3.999 | 0 | 0.01 | 0.006 | 2.091 |
| Operating Cash Flow
| -146.697 | -152.862 | -240.824 | -239.683 | -149.296 | -86.783 | -36.702 | -23.09 | -13.269 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -0.778 | -0.841 | -5.97 | -5.316 | -4.935 | -1.125 | -0.406 | -0.223 | -0.142 |
| Acquisitions Net
| -13.327 | 33.468 | -4 | 0.007 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -322.572 | -322.767 | -335.375 | -1,096.769 | -817.142 | -1.069 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 335.899 | 289.299 | 518.2 | 1,132.129 | 361.996 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 13.327 | -33.468 | 3.993 | -1.592 | -0.441 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 12.549 | -34.309 | 176.848 | 28.459 | -460.522 | -2.194 | -0.406 | -0.223 | -0.142 |
| Financing Activities: | |||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 149.747 | 163.778 | 8.589 | 226.801 | 432.4 | 185.933 | 129.112 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 152.004 | 164.994 | 14.89 | 226.801 | 436.374 | 185.987 | 176.401 | 54.997 | 38.418 |
| Financing Cash Flow
| 152.004 | 164.994 | 14.89 | 226.801 | 436.374 | 185.987 | 176.401 | 54.997 | 38.418 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| 0.91 | -0.145 | 0.252 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 18.766 | -22.322 | -48.834 | 15.577 | -173.444 | 97.01 | 139.293 | 31.684 | 25.007 |
| Cash At End Of Period
| 83.507 | 64.741 | 87.063 | 135.897 | 120.32 | 293.764 | 196.754 | 57.461 | 25.777 |